Mereo Biopharma Group Plc ADR (MREO)

$4.38 +0.03 (0.69%)
Market Cap 530.17M
Revenue (ttm) 10.00M
Net Income (ttm) -29.47M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 28,075
Avg Vol 812,584
Day's Range N/A - N/A
Shares Out 140.26M
Stochastic %K 30%
Beta 0.88
Analysts Strong Sell
Price Target $6.80

Company Profile

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of rare diseases in the United Kingdom and the United States. The company develops Setrusumab, an antibody for the treatment of osteogenesis imperfecta; Alvelestat, an oral small molecule that is in Phase II clinical trial to treat Alpha-1 anti-trypsin deficiency associated lung disease; and Vantictumab, an anti-FZD monoclonal antibody for the treatment of autosomal dominant osteope...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 33 3023 7300
Address:
One Cavendish Place, 4th Floor, London, United Kingdom
Spinaroonie
Spinaroonie Jul. 2 at 5:13 PM
$MREO its dead one more move up selling at a modest profit, no legs left in this stock
1 · Reply
Spinaroonie
Spinaroonie Jul. 1 at 7:51 PM
$MREO this has less then a week to break.35 or its done
1 · Reply
Spinaroonie
Spinaroonie Jul. 1 at 4:50 PM
$MREO getting so close to breaking out!! LETS GO
1 · Reply
AutisticRetardo
AutisticRetardo Jul. 1 at 3:40 AM
$MREO RS incoming
2 · Reply
LDT79
LDT79 Jun. 30 at 8:01 PM
$MREO dude!!! What was that close?
1 · Reply
Spinaroonie
Spinaroonie Jun. 30 at 8:01 PM
$MREO well that drop sucked
1 · Reply
theSmokingBuzzard
theSmokingBuzzard Jun. 30 at 6:59 PM
$MREO 👀
1 · Reply
gotrocks
gotrocks Jun. 29 at 8:14 PM
$MREO what was that at the end of the day?
0 · Reply
Rojingeorge
Rojingeorge Jun. 29 at 10:52 AM
$MREO Mathematical Analysis of MREO’s On-Balance Volume (OBV)The (OBV) indicator acts as a running total of cumulative market volume. It adds volume on up-days and subtracts it on down-days.When analyzing MREOcurrent compression, the OBV line reveals a clear bullish divergence, confirming that the stock is undergoing heavy institutional accumulation rather than distribution:The Price Behavior: The stock price has slid from its historical highs and is moving completely sideways. It is locked inside a strict horizontal wedge between $0.26 and $0.32.TheOBV Indicator Line: While the price remains flat and boring, the cumulative OBV line has steadily moved upward.The Technical Verification: BecauseOBV rises while prices remain flat, it proves that the volume on green days is significantly higher than the volume on red days. Large funds (like Rubric and EcoR1) are soaking up shares quietly. They buy on up-days but completely step back on down-days to avoid pushing the price higher - NFA
1 · Reply
ka1954
ka1954 Jun. 26 at 6:50 PM
$MREO is the share count of 798m right? how much cash do they have?
1 · Reply
Latest News on MREO
4basebio Announces Appointment of Chief Financial Officer and Board Changes

Thu, 14 May 2026 07:00:00 -0400 - 7 weeks ago

4basebio Announces Appointment of Chief Financial Officer and Board Changes

Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Tue, 12 May 2026 07:30:00 -0400 - 7 weeks ago

Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Class Action Filed Against Mereo BioPharma Group plc (MREO) - April 6, 2026 Deadline to Join – Contact Levi & Korsinsky

Mon, 06 Apr 2026 16:00:00 -0400 - 3 months ago

Class Action Filed Against Mereo BioPharma Group plc (MREO) - April 6, 2026 Deadline to Join – Contact Levi & Korsinsky

MREO DEADLINE TODAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

Mon, 06 Apr 2026 15:18:00 -0400 - 3 months ago

MREO DEADLINE TODAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

MREO DEADLINE ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Mon, 06 Apr 2026 13:05:00 -0400 - 3 months ago

MREO DEADLINE ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

MEREO LAWSUIT DEADLINE TODAY: Bragar Eagel & Squire, P.C. Urges Mereo BioPharma Stockholders with Large Losses to Contact the Firm Regarding Their Rights

Mon, 06 Apr 2026 10:48:00 -0400 - 3 months ago

MEREO LAWSUIT DEADLINE TODAY: Bragar Eagel & Squire, P.C. Urges Mereo BioPharma Stockholders with Large Losses to Contact the Firm Regarding Their Rights

MREO FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Mon, 06 Apr 2026 09:18:00 -0400 - 3 months ago

MREO FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO

Mon, 06 Apr 2026 03:45:00 -0400 - 3 months ago

Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

Mon, 06 Apr 2026 02:32:00 -0400 - 3 months ago

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

MREO Deadline: MREO Investors with Losses in Excess of $100K Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

Sun, 05 Apr 2026 16:59:00 -0400 - 3 months ago

MREO Deadline: MREO Investors with Losses in Excess of $100K Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

MREO DEADLINE TOMORROW: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Sun, 05 Apr 2026 13:00:00 -0400 - 3 months ago

MREO DEADLINE TOMORROW: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

MREO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Sun, 05 Apr 2026 08:18:00 -0400 - 3 months ago

MREO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

MREO DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Sat, 04 Apr 2026 10:59:00 -0400 - 3 months ago

MREO DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Bronstein, Gewirtz & Grossman LLC Urges Mereo BioPharma Group plc Investors to Act: Class Action Filed Alleging Investor Harm

Fri, 03 Apr 2026 12:00:00 -0400 - 3 months ago

Bronstein, Gewirtz & Grossman LLC Urges Mereo BioPharma Group plc Investors to Act: Class Action Filed Alleging Investor Harm

MREO FINAL DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

Fri, 03 Apr 2026 11:41:00 -0400 - 3 months ago

MREO FINAL DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

MREO Deadline: Rosen Law Firm Urges Mereo BioPharma Group plc (NASDAQ: MREO) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Fri, 03 Apr 2026 11:33:00 -0400 - 3 months ago

MREO Deadline: Rosen Law Firm Urges Mereo BioPharma Group plc (NASDAQ: MREO) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

MREO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Mereo BioPharma Investors of Securities Class Action Deadline on April 6, 2026

Fri, 03 Apr 2026 09:08:00 -0400 - 3 months ago

MREO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Mereo BioPharma Investors of Securities Class Action Deadline on April 6, 2026

DEADLINE APPROACHING: Berger Montague Advises BioPharma Group PLC (NASDAQ: MREO) Investors to Inquire About a Securities Fraud Class Action by April 6, 2026

Thu, 02 Apr 2026 12:21:00 -0400 - 3 months ago

DEADLINE APPROACHING: Berger Montague Advises BioPharma Group PLC (NASDAQ: MREO) Investors to Inquire About a Securities Fraud Class Action by April 6, 2026

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

Thu, 02 Apr 2026 10:17:00 -0400 - 3 months ago

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO

Thu, 02 Apr 2026 10:00:00 -0400 - 3 months ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO

MREO DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Wed, 01 Apr 2026 18:30:00 -0400 - 3 months ago

MREO DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Mereo BioPharma Group plc (MREO) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit

Wed, 01 Apr 2026 12:26:00 -0400 - 3 months ago

Mereo BioPharma Group plc (MREO) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit

MREO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Wed, 01 Apr 2026 09:50:00 -0400 - 3 months ago

MREO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Shareholders that lost money on Mereo BioPharma Group plc(MREO) should contact Levi & Korsinsky about pending Class Action - MREO

Wed, 01 Apr 2026 09:00:00 -0400 - 3 months ago

Shareholders that lost money on Mereo BioPharma Group plc(MREO) should contact Levi & Korsinsky about pending Class Action - MREO

MREO Deadline: MREO Investors with Losses in Excess of $100K Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

Tue, 31 Mar 2026 18:37:00 -0400 - 3 months ago

MREO Deadline: MREO Investors with Losses in Excess of $100K Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

MREO DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

Tue, 31 Mar 2026 17:01:00 -0400 - 3 months ago

MREO DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines – MREO

Tue, 31 Mar 2026 15:50:00 -0400 - 3 months ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines – MREO

MEREO BIOPHARMA GROUP PLC (MREO) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by April 6, 2026

Tue, 31 Mar 2026 12:21:00 -0400 - 3 months ago

MEREO BIOPHARMA GROUP PLC (MREO) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by April 6, 2026

MREO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Mereo BioPharma Group plc Securities Lawsuit -- The Gross Law Firm

Tue, 31 Mar 2026 09:00:00 -0400 - 3 months ago

MREO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Mereo BioPharma Group plc Securities Lawsuit -- The Gross Law Firm

MREO FINAL DEADLINE: ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Mon, 30 Mar 2026 22:58:00 -0400 - 3 months ago

MREO FINAL DEADLINE: ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

MREO EQUITY ALERT: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Mon, 30 Mar 2026 18:51:00 -0400 - 3 months ago

MREO EQUITY ALERT: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

Mon, 30 Mar 2026 10:00:00 -0400 - 3 months ago

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

Mon, 30 Mar 2026 03:43:00 -0400 - 3 months ago

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO

Mon, 30 Mar 2026 03:42:00 -0400 - 3 months ago

Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO

MREO FINAL DEADLINE: ROSEN, LONGSTANDING INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Sun, 29 Mar 2026 22:51:00 -0400 - 3 months ago

MREO FINAL DEADLINE: ROSEN, LONGSTANDING INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

MREO FINAL DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Sat, 28 Mar 2026 22:23:00 -0400 - 3 months ago

MREO FINAL DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

MREO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Sat, 28 Mar 2026 10:03:00 -0400 - 3 months ago

MREO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

MREO FINAL DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Fri, 27 Mar 2026 16:05:00 -0400 - 3 months ago

MREO FINAL DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Bronstein, Gewirtz & Grossman LLC Urges Mereo BioPharma Group plc Investors to Act: Class Action Filed Alleging Investor Harm

Fri, 27 Mar 2026 12:00:00 -0400 - 3 months ago

Bronstein, Gewirtz & Grossman LLC Urges Mereo BioPharma Group plc Investors to Act: Class Action Filed Alleging Investor Harm

MREO Shareholder Alert: Mereo BioPharma Group plc Securities Class Action Lawsuit Investors With Losses May Join — The Gross Law Firm

Fri, 27 Mar 2026 11:03:00 -0400 - 3 months ago

MREO Shareholder Alert: Mereo BioPharma Group plc Securities Class Action Lawsuit Investors With Losses May Join — The Gross Law Firm

MREO INVESTOR ALERT: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Fri, 27 Mar 2026 09:31:00 -0400 - 3 months ago

MREO INVESTOR ALERT: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO

Thu, 26 Mar 2026 10:00:00 -0400 - 3 months ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO

INVESTOR ALERT: Berger Montague Advises Mereo BioPharma Group PLC (NASDAQ: MREO) Investors to Inquire About a Securities Fraud Class Action by April 6, 2026

Thu, 26 Mar 2026 08:55:00 -0400 - 3 months ago

INVESTOR ALERT: Berger Montague Advises Mereo BioPharma Group PLC (NASDAQ: MREO) Investors to Inquire About a Securities Fraud Class Action by April 6, 2026

MREO Deadline: MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

Wed, 25 Mar 2026 22:52:00 -0400 - 3 months ago

MREO Deadline: MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

MREO FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

Wed, 25 Mar 2026 18:16:00 -0400 - 3 months ago

MREO FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

MREO FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Wed, 25 Mar 2026 18:08:00 -0400 - 3 months ago

MREO FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

MREO Investor Alert - Mereo BioPharma Group plc Investors with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit

Wed, 25 Mar 2026 17:06:00 -0400 - 3 months ago

MREO Investor Alert - Mereo BioPharma Group plc Investors with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit

MEREO LAWSUIT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Mereo BioPharma Stockholders with Large Losses to Contact the Firm Before April 6th

Wed, 25 Mar 2026 16:04:00 -0400 - 3 months ago

MEREO LAWSUIT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Mereo BioPharma Stockholders with Large Losses to Contact the Firm Before April 6th

MREO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Mereo BioPharma Investors of Securities Class Action Deadline on April 6, 2026

Wed, 25 Mar 2026 12:22:00 -0400 - 3 months ago

MREO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Mereo BioPharma Investors of Securities Class Action Deadline on April 6, 2026

Shareholders of Mereo BioPharma Group plc Should Contact Levi & Korsinsky Before April 6, 2026 to Discuss Your Rights - MREO

Wed, 25 Mar 2026 09:00:00 -0400 - 3 months ago

Shareholders of Mereo BioPharma Group plc Should Contact Levi & Korsinsky Before April 6, 2026 to Discuss Your Rights - MREO

Shareholders Sue Mereo BioPharma (MREO) Over Brittle Bone Drug Claims

2026-03-24T11:16:17.000Z - 3 months ago

Shareholders Sue Mereo BioPharma (MREO) Over Brittle Bone Drug Claims

NVS RARE

Mereo BioPharma downgraded to Neutral from Overweight at JPMorgan

2026-03-23T09:10:08.000Z - 3 months ago

Mereo BioPharma downgraded to Neutral from Overweight at JPMorgan

Mereo BioPharma downgraded to Neutral from Overweight at JPMorgan

2026-03-20T20:50:18.000Z - 3 months ago

Mereo BioPharma downgraded to Neutral from Overweight at JPMorgan

Mereo BioPharma Reports Full Year 2025 Financial Results and Provides Corporate Highlights

Mar 19, 2026, 8:30 AM EDT - 3 months ago

Mereo BioPharma Reports Full Year 2025 Financial Results and Provides Corporate Highlights

Stockholders Who Lost Money Investing in Mereo BioPharma Group plc Should Contact Robbins LLP for Information About Recovering Their Losses from MREO

Feb 18, 2026, 2:11 PM EST - 4 months ago

Stockholders Who Lost Money Investing in Mereo BioPharma Group plc Should Contact Robbins LLP for Information About Recovering Their Losses from MREO

Mereo BioPharma sees cash runway into mid-2027

2026-01-12T13:20:17.000Z - 6 months ago

Mereo BioPharma sees cash runway into mid-2027

Mereo BioPharma downgraded to Hold from Buy at Jefferies

2025-12-30T01:50:19.000Z - 6 months ago

Mereo BioPharma downgraded to Hold from Buy at Jefferies

RARE

Mereo BioPharma price target lowered to $1, ‘Fresh Pick’ removed at Baird

2025-12-29T18:50:09.000Z - 6 months ago

Mereo BioPharma price target lowered to $1, ‘Fresh Pick’ removed at Baird

Mereo BioPharma price target lowered to $1 from $6 at BTIG

2025-12-29T18:40:08.000Z - 6 months ago

Mereo BioPharma price target lowered to $1 from $6 at BTIG

Mereo BioPharma downgraded to Market Perform from Outperform at LifeSci Capital

2025-12-29T18:10:09.000Z - 6 months ago

Mereo BioPharma downgraded to Market Perform from Outperform at LifeSci Capital

These biotech stocks are getting hammered by shocking brittle-bone treatment study results

Dec 29, 2025, 1:05 PM EST - 6 months ago

These biotech stocks are getting hammered by shocking brittle-bone treatment study results

RARE

Mereo BioPharma price target lowered to $3 from $6 at Cantor Fitzgerald

2025-12-29T17:10:17.000Z - 6 months ago

Mereo BioPharma price target lowered to $3 from $6 at Cantor Fitzgerald

Mereo Biopharma Stock (MREO) Collapses over 90% after Failed Trials

2025-12-29T16:34:28.000Z - 6 months ago

Mereo Biopharma Stock (MREO) Collapses over 90% after Failed Trials

AZN INSM RCUS

Mereo BioPharma Group trading resumes

2025-12-29T13:55:07.000Z - 6 months ago

Mereo BioPharma Group trading resumes

Mereo BioPharma Announces Phase 3 ORBIT and COSMIC Results for Setrusumab (UX143) in Osteogenesis Imperfecta

Dec 29, 2025, 8:31 AM EST - 6 months ago

Mereo BioPharma Announces Phase 3 ORBIT and COSMIC Results for Setrusumab (UX143) in Osteogenesis Imperfecta

āshibio Expands Clinical Pipeline with Vantictumab, a First-In-Class Antibody for Autosomal Dominant Osteopetrosis Type 2

Aug 19, 2025, 8:30 AM EDT - 11 months ago

āshibio Expands Clinical Pipeline with Vantictumab, a First-In-Class Antibody for Autosomal Dominant Osteopetrosis Type 2

Mereo BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Highlights

Aug 12, 2025, 7:35 AM EDT - 11 months ago

Mereo BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Highlights

Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights

May 13, 2025, 7:30 AM EDT - 1 year ago

Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights

Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights

Mar 26, 2025, 7:30 AM EDT - 1 year ago

Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights

Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Healthcare Conference

Mar 5, 2025, 7:30 AM EST - 1 year ago

Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Healthcare Conference

Mereo BioPharma Provides Update on Lead Clinical Programs

Jan 12, 2025, 11:05 AM EST - 1 year ago

Mereo BioPharma Provides Update on Lead Clinical Programs

Mereo BioPharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 7, 2025, 7:30 AM EST - 1 year ago

Mereo BioPharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference

Nov 14, 2024, 7:30 AM EST - 1 year ago

Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference

Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 12, 2024, 7:30 AM EST - 1 year ago

Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference

Sep 12, 2024, 5:35 PM EDT - 1 year ago

Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference

Mereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 13, 2024, 8:00 AM EDT - 2 years ago

Mereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market

Jun 14, 2024, 7:50 AM EDT - 2 years ago

Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market

Mereo BioPharma to Participate in Fireside Chat at the Jefferies Global Healthcare Conference

May 30, 2024, 7:30 AM EDT - 2 years ago

Mereo BioPharma to Participate in Fireside Chat at the Jefferies Global Healthcare Conference

Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 15, 2024, 4:01 PM EDT - 2 years ago

Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

Apr 3, 2024, 7:30 AM EDT - 2 years ago

Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update

Mar 27, 2024, 4:01 PM EDT - 2 years ago

Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update

Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma Conference

Mar 5, 2024, 7:30 AM EST - 2 years ago

Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma Conference

Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments

Jan 8, 2024, 7:00 AM EST - 2 years ago

Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments

Mereo BioPharma Reports on Recent Program Developments and Provides Financial Update

Oct 23, 2023, 4:01 PM EDT - 2 years ago

Mereo BioPharma Reports on Recent Program Developments and Provides Financial Update

Mereo BioPharma to Participate in Fireside Chat at the 2023 Cantor Global Healthcare Conference

Sep 21, 2023, 7:00 AM EDT - 3 years ago

Mereo BioPharma to Participate in Fireside Chat at the 2023 Cantor Global Healthcare Conference

Mereo BioPharma Reports Interim Financial Results for the Six Months Ended June 30, 2023 and Provides Corporate Update

Sep 7, 2023, 7:30 AM EDT - 3 years ago

Mereo BioPharma Reports Interim Financial Results for the Six Months Ended June 30, 2023 and Provides Corporate Update

Spinaroonie
Spinaroonie Jul. 2 at 5:13 PM
$MREO its dead one more move up selling at a modest profit, no legs left in this stock
1 · Reply
Spinaroonie
Spinaroonie Jul. 1 at 7:51 PM
$MREO this has less then a week to break.35 or its done
1 · Reply
Spinaroonie
Spinaroonie Jul. 1 at 4:50 PM
$MREO getting so close to breaking out!! LETS GO
1 · Reply
AutisticRetardo
AutisticRetardo Jul. 1 at 3:40 AM
$MREO RS incoming
2 · Reply
LDT79
LDT79 Jun. 30 at 8:01 PM
$MREO dude!!! What was that close?
1 · Reply
Spinaroonie
Spinaroonie Jun. 30 at 8:01 PM
$MREO well that drop sucked
1 · Reply
theSmokingBuzzard
theSmokingBuzzard Jun. 30 at 6:59 PM
$MREO 👀
1 · Reply
gotrocks
gotrocks Jun. 29 at 8:14 PM
$MREO what was that at the end of the day?
0 · Reply
Rojingeorge
Rojingeorge Jun. 29 at 10:52 AM
$MREO Mathematical Analysis of MREO’s On-Balance Volume (OBV)The (OBV) indicator acts as a running total of cumulative market volume. It adds volume on up-days and subtracts it on down-days.When analyzing MREOcurrent compression, the OBV line reveals a clear bullish divergence, confirming that the stock is undergoing heavy institutional accumulation rather than distribution:The Price Behavior: The stock price has slid from its historical highs and is moving completely sideways. It is locked inside a strict horizontal wedge between $0.26 and $0.32.TheOBV Indicator Line: While the price remains flat and boring, the cumulative OBV line has steadily moved upward.The Technical Verification: BecauseOBV rises while prices remain flat, it proves that the volume on green days is significantly higher than the volume on red days. Large funds (like Rubric and EcoR1) are soaking up shares quietly. They buy on up-days but completely step back on down-days to avoid pushing the price higher - NFA
1 · Reply
ka1954
ka1954 Jun. 26 at 6:50 PM
$MREO is the share count of 798m right? how much cash do they have?
1 · Reply
Spinaroonie
Spinaroonie Jun. 26 at 6:08 PM
$MREO whats app groups attacking this stock today. Ugly
1 · Reply
Spinaroonie
Spinaroonie Jun. 26 at 5:59 PM
$MREO i think we just got screwed today
0 · Reply
mwhite9869
mwhite9869 Jun. 26 at 1:09 PM
$MREO New here. Grabbed some at an avg. of 0.29$. Looks like lots of growth opportunity here. Anything I should know, just getting into this? TIA and GLA!
1 · Reply
JSP_Dilution_Player
JSP_Dilution_Player Jun. 25 at 3:17 PM
$MREO i will revisit this and going to watch it for sure. It appears that this is play for Sept into end of year. They can still drop news anytime. Good Luck
1 · Reply
Spinaroonie
Spinaroonie Jun. 24 at 10:49 PM
$MREO hope this rebounds, last few days was giving me hope, now im not so sure
0 · Reply
LDT79
LDT79 Jun. 24 at 8:18 PM
$MREO fire her pleeeeaaasseeee!!!
0 · Reply
theSmokingBuzzard
theSmokingBuzzard Jun. 24 at 7:54 PM
$MREO Ouch 😭
0 · Reply
JSP_Dilution_Player
JSP_Dilution_Player Jun. 24 at 7:09 PM
$MREO 400k block
1 · Reply
Spinaroonie
Spinaroonie Jun. 24 at 6:41 PM
$MREO POS
0 · Reply
JSP_Dilution_Player
JSP_Dilution_Player Jun. 24 at 5:42 PM
$MREO market is red today and this is red with it.
0 · Reply
Spinaroonie
Spinaroonie Jun. 24 at 3:54 PM
$MREO well this is losing steam
0 · Reply
LDT79
LDT79 Jun. 24 at 3:32 PM
$MREO mmmm, should have waited to buy back. Penny flippers will flip - CEO is an under deliverer
0 · Reply